Cargando…
A Comparison of Doxorubicin-Resistant Colon Cancer LoVo and Leukemia HL60 Cells: Common Features, Different Underlying Mechanisms
Chemoresistance causes cancer relapse and metastasis, thus remaining the major obstacle to cancer therapy. While some light has been shed on the underlying mechanisms, it is clear that chemoresistance is a multifaceted problem strictly interconnected with the high heterogeneity of neoplastic cells....
Autores principales: | Locatelli, Laura, Cazzaniga, Alessandra, Fedele, Giorgia, Zocchi, Monica, Scrimieri, Roberta, Moscheni, Claudia, Castiglioni, Sara, Maier, Jeanette A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8929017/ https://www.ncbi.nlm.nih.gov/pubmed/34067290 http://dx.doi.org/10.3390/cimb43010014 |
Ejemplares similares
-
Magnesium homeostasis in colon carcinoma LoVo cells sensitive or resistant to doxorubicin
por: Castiglioni, Sara, et al.
Publicado: (2015) -
Laminarin-induced apoptosis in human colon cancer LoVo cells
por: JI, CHEN-FENG, et al.
Publicado: (2014) -
Effects of ADMA on gene expression and metabolism in serum-starved LoVo cells
por: Zheng, Ningning, et al.
Publicado: (2016) -
Inhibition of protein kinase C-alpha isoform enhances the P-glycoprotein expression and the survival of LoVo human colon adenocarcinoma cells to doxorubicin exposure.
por: La Porta, C. A., et al.
Publicado: (1998) -
Maize polyamine oxidase in the presence of spermine/spermidine induces the apoptosis of LoVo human colon adenocarcinoma cells
por: Ohkubo, Shinji, et al.
Publicado: (2019)